Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,344.00
(
-1.59%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.44
(
3.84%
)
Bitcoin
70,464.00
(
0.81%
)
News Focus
News Focus
Post# of 257264
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 103243

Wednesday, 09/01/2010 1:16:17 PM

Wednesday, September 01, 2010 1:16:17 PM

Post# of 257264

No patent cliff, although I suppose there is some chance of another entrant down the line.

The only other vendor who has even submitted an ANDA for the Lovenox prefilled syringe is Amphastar, and we can surmise from various clues that the Amphastar ANDA is DOA. (HSP submitted a Lovenox ANDA for the vial formulation only, which is a minuscule portion of the US Lovenox market.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today